BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18440705)

  • 1. Prognostic factors for renal cell carcinoma.
    Furniss D; Harnden P; Ali N; Royston P; Eisen T; Oliver RT; Hancock BW;
    Cancer Treat Rev; 2008 Aug; 34(5):407-26. PubMed ID: 18440705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic models and algorithms in renal cell carcinoma.
    Lane BR; Kattan MW
    Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic biomarkers in renal cell carcinoma.
    Jiang Z
    Expert Rev Mol Diagn; 2007 May; 7(3):293-307. PubMed ID: 17489736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and biological significance of lymph node spreading in renal cell carcinoma.
    Patard JJ
    Eur Urol; 2006 Feb; 49(2):220-2. PubMed ID: 16426737
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic markers in renal cell carcinoma.
    Ljungberg B
    Curr Opin Urol; 2007 Sep; 17(5):303-8. PubMed ID: 17762621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy.
    Lam JS; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6304S-9S. PubMed ID: 15448022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in renal cell carcinoma.
    Shuch BM; Lam JS; Belldegrun AS; Figlin RA
    Semin Oncol; 2006 Oct; 33(5):563-75. PubMed ID: 17045085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).
    Gelb AB
    Cancer; 1997 Sep; 80(5):981-6. PubMed ID: 9307202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors in renal cell carcinoma].
    Letang N; Cabaniols L; Pouessel D; Robert M; Iborra F; Culine S; Patard JJ; Guiter J; Thuret R
    Bull Cancer; 2009 Apr; 96(4):475-84. PubMed ID: 19357021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers for renal cell carcinoma: impact on diagnosis and treatment.
    Zhou M; Rubin MA
    Semin Urol Oncol; 2001 May; 19(2):80-7. PubMed ID: 11354537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of molecular markers in the staging of renal cell carcinoma.
    Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    BJU Int; 2007 May; 99(5 Pt B):1208-11. PubMed ID: 17441912
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular prognostic factor in renal cell carcinoma.
    Shimazui T; Oosterwijk E; Debruyne FM; Schalken JA
    Semin Urol Oncol; 1996 Nov; 14(4):250-5. PubMed ID: 8946626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma.
    Shah JB; Margulis V
    Expert Rev Anticancer Ther; 2010 Jun; 10(6):837-42. PubMed ID: 20553209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
    Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
    Liu Z; Lv J; Ding K; Fu Q; Cao Q; Wang F
    Int J Urol; 2009 Mar; 16(3):268-73. PubMed ID: 19087209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma.
    Gacci M; Serni S; Lapini A; Vittori G; Alessandrini M; Nesi G; Palli D; Carini M
    J Urol; 2009 Feb; 181(2):843-8. PubMed ID: 19095263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The staging of renal cell carcinoma.
    Shuch B; La Rochelle JC; Pantuck AJ; Belldegrun AS
    Curr Opin Urol; 2008 Sep; 18(5):455-61. PubMed ID: 18670267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
    Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
    J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
    Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.